Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
用户VFEElx7FS5VY
1个月前
49
10
已完结
1. 系统已在2025-10-22 15:59:13对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S1474-4422(22)00400-8
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1474442222004008
其他信息:
出版社: Elsevier BV
作者: Michael J Soileau; Jason Aldred; Kumar Budur; Nahome Fisseha; Victor SC Fung; Anna Jeong; Thomas E Kimber; Kevin Klos; Irene Litvan; Daniel O'Neill; Weining Z Robieson; Meredith A Spindler; David G Standaert; Saritha Talapala; Eleni Okeanis Vaou; Hui Zheng; Maurizio F Facheris; Robert A Hauser
